Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Benjamin W Teh, Monica A Slavin, Simon J Harrison & Leon J Worth. (2015) Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization. Expert Review of Anti-infective Therapy 13:11, pages 1325-1336.
Read now
Read now
Juan Li, Beihui Huang, Ying Li, Dong Zheng, Zhenhai Zhou & Junru Liu. (2015) Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant. Leukemia & Lymphoma 56:6, pages 1710-1717.
Read now
Read now
Articles from other publishers (16)
Jun Ho Yi, Jung Lim Lee, Yoo Jin Lee, Hye Jin Kang, Young Hoon Park, Young Jin Yuh, Sung-Nam Lim, Hyo Jung Kim, Sung-Hoon Jung, Je-Jung Lee, Hee Jeong Cho, Joon Ho Moon, Ho-Young Yhim & Kihyun Kim. (2023) Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
Chenyao Lin, Hui Shen, Shuimei Zhou, Minghui Liu, Anjie Xu, Shuang Huang, Changxin Shen & Fuling Zhou. (2020) Assessment of infection in newly diagnosed multiple myeloma patients: risk factors and main characteristics. BMC Infectious Diseases 20:1.
Crossref
Crossref
Lu Han, Jian Zhou, Keshu Zhou, Xinghu Zhu, Lingdi Zhao, Baijun Fang, Qingsong Yin, Xudong Wei, Hu Zhou, Linlin Li, Bengling Xu, Jishuai Zhang, Yongping Song & Quanli Gao. (2020) Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus. Journal for ImmunoTherapy of Cancer 8:2, pages e000927.
Crossref
Crossref
Melda TURKEN, Şükran KÖSE, Ayşe ÖZKAN ACAR, Cengiz CEYLAN, Hazal ALBAYRAK & Eren ARKALI. (2020) Hepatitis B seroprevalence in hematological oncology patients. The European Research Journal 6:2, pages 87-91.
Crossref
Crossref
Xuzhao Zhang, Yun Liang, Xian Li, Weiqin Wang, Jiefeng Tong & Yang Xu. (2020) Clearance of HBsAg in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-HBV drug. Medicine 99:40, pages e22642.
Crossref
Crossref
Dan Guo, Peipei Xu, Chaoyang Guan, Yong Xu, Yonggong Yang, Jingyan Xu, Rongfu Zhou & Bing Chen. (2019) Hepatitis B virus infection and 1q21 amplification in multiple myeloma. Oncology Letters.
Crossref
Crossref
Chan Woo ChoNuri LeeGyu-Seong ChoiJong Man KimChoon Hyuck David KwonJae-Won Joh. (2018) Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report. Annals of Surgical Treatment and Research 94:4, pages 216.
Crossref
Crossref
Y. Li, Y. Li, L. Zhang & W. Li. (2017) Hepatitis C virus infection and risk of multiple myeloma: Evidence from a meta-analysis based on 17 case-control studies. Journal of Viral Hepatitis 24:12, pages 1151-1159.
Crossref
Crossref
Pan Zhao, Qing Gao, Qiulian He & Jing Tan. (2017) Prevalence and clinical outcomes of hepatitis B virus infection in patients with aplastic anemia. International Journal of Hematology 106:4, pages 484-489.
Crossref
Crossref
Ankur Varma, Laura Biritxinaga, Rima M. Saliba, Maximilian Stich, Sarah Francesca Jauch, Aimaz Afrough, Medhavi Honhar, Uday R. Popat, Mehnaz A. Shafi, Nina Shah, Qaiser Bashir, Yvonne Dinh, Chitra Hosing, Richard E. Champlin & Muzaffar H. Qazilbash. (2017) Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation 23:4, pages 581-587.
Crossref
Crossref
Y. Li, O. Bai, C. Liu, Z. Du, X. Wang, G. Wang & W. Li. (2016) Association between hepatitis B virus infection and risk of multiple myeloma: a systematic review and meta-analysis. Internal Medicine Journal 46:3, pages 307-314.
Crossref
Crossref
Man Fai Law, Rita Ho, Carmen K M Cheung, Lydia H P Tam, Karen Ma, Kent C Y So, Bonaventure Ip, Jacqueline So, Jennifer Lai, Joyce Ng & Tommy H C Tam. (2016) Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy. World Journal of Gastroenterology 22:28, pages 6484.
Crossref
Crossref
Samir Dalia, Kelli Dunker, Lubomir Sokol & Rahul Mhaskar. (2015) Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies. Leukemia Research 39:12, pages 1325-1333.
Crossref
Crossref
Samantha Therezinha Almeida Pereira Leite, Marilene Borges da Silva, Marco Andrey Pepato, Francisco Jos? Dutra Souto, Raquel Alves dos Santos & Carmen Lucia Bassi-Branco. (2014) Increased frequency of micronuclei in the lymphocytes of patients chronically infected with hepatitis B or hepatitis C virus. Mem?rias do Instituto Oswaldo Cruz 109:1, pages 15-20.
Crossref
Crossref
A. El Mekkaoui, Z. Benbrahim, O. El Mesbahi, A. Ibrahimi & N. Aqodad. (2013) Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreusePreemptive treatment of hepatitis B reactivation in patients receiving anticancer chemotherapy. Journal Africain du Cancer / African Journal of Cancer 6:1, pages 47-53.
Crossref
Crossref
Juan Li, Junru Liu, Beihui Huang, Dong Zheng, Mei Chen, Zhenhai Zhou, Duorong Xu & Waiyi Zou. (2013) Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation. Tumor Biology 34:3, pages 1723-1728.
Crossref
Crossref